ARPC5 and cancer: The results revealed that ARPC5 expression was prominently related to immune subtypes in a number of cancers(Figures 7A–T), which included BLCA (p = 3.38e-05), BRCA (p = 3.49e-21), CESC (p = 1.31e-02), KICH (p = 4.49e-02), KIRC (p = 2.79e-09), LGG (p = 2.42e-19), LIHC (p = 2e-02), LUAD (p = 5.6e-07), PAAD (p = 2.19e-03), OV (p = 4.67e-03), PCPG (p = 5.04e-03), PRAD (p = 8.91e-07), READ (p = 1.34e-02), SARC (p = 5.72e-03), SKCM (p = 1.15e-02), STAD (p = 1.08e-08), TGCT (p = 3.52e-02), THCA (p = 1.97e-02), UCS (p = 1.44e-03), and UCEC (p = 7.99e-05).